Summary
Alzheimer’s disease is a neurodegenerative disorder comprising multisystem atrophies probably caused by multifactorial processes. The disease is characterized by typical neuropathology, impaired synaptic function and massive cell loss. The pathobiochemistry of this disorder involves oxidative stress, which accumulates free radicals leading to excessive lipid peroxidation and neuronal degeneration in certain brain regions. Moreover, radical induced disturbances of DNA, proteins and lipid membranes have been measured. The hypothesis has been proposed that cellular events involving oxidative stress may be one basic pathway leading to neurodegeneration in Alzheimer’s disease. In this work we report evidence for increased oxidative stress and disturbed defense mechanisms in Alzheimer’s disease, which may result in a self-propagating cascade of neurodegenerative events. Furthermore it is evident from experimental data, that aggregation of β-amyloid and β-amyloid toxicity is favourably caused by oxidative stress. Therefore, oxidative stress plays a key role in the conversion of soluble to unsoluble β-amyloid, suggesting that oxidative stress is primary to the β-amyloid cascade.
Alzheimer’s disease represents the most common cause of senile dementia. However, since the first clinical and neuropathological description 90 years ago (Alzheimer, 1907) etiology and exact pathogenesis of this disease is still not clear. Pathological presentation of Alzheimers disease involves regionalized, transmitter-specific neuronal loss (Braak and Braak, 1991; Greenamyre and Maragos, 1993), synaptic pathology (Adams, 1991) and an accumulation of intracellular and extracellular protein aggregates presenting as neurofibrillary tangles and senile plaques respectively. These prominent neuropathological abnormalities have focused scientific interest on several independent parameters, which have been suggested to be responsible for these pathological changes, including hyperphosphorylation of cytoskeletal proteins (tau-protein), metabolism of β-amyloid and the β-amyloid precursor protein (APP) and the polymorphism of apolipoprotein E (APO-E). There is strong evidence that changes of brain glucose metabolism (Hoyer, 1996), mitochondrial disturbances (Wallace, 1992; Beal, 1996), excitotoxicity (Shaw, 1992), immunological processes (Bauer and Berger, 1993) and the biosynthesis of advanced glycation end products (AGEs) (Thome et al., 1996) might be primary responsible for Alzheimer’s disease pathology. At present, there is no conclusive hypothesis to unify the enormous number of neuropathological and neurochemical findings. It has been concluded, that Alzheimer’s disease might be a heterogenous disease (St George-Hyslop et al., 1990), with a wide spectrum of etiological factors, each of which is able to originate a cascade of pathological processes, leading to an at least uniform condition presenting clinically as dementia.
However, there is now a confluence of opinion that free radical oxidative stress plays a key role among the factors of this pathogenetic cascade of Alzheimer’s disease (Benzi and Moretti, 1995). Oxygen free radicals are of particular interest, because of their interactions with almost all hypotheses about the pathogenesis of Alzheimer’s disease, and the formation of unsoluble beta-amyloid in particular. Moreover, damage due to oxidative stress accumulates with age (Benzi et al., 1989) and age is the most important risk factor for Alzheimer’s disease (Bachman et al., 1993).
Oxygen free radicals are formed as by-products of respiration and oxidative metabolism in all aerobic organisms. It is well established that the generation of radical molecules can lead to damage or destruction of a variety of tissues (McCord and Fridovich, 1988). Consequences of excessive reactive oxygen species are lipid peroxidation, oxidation of proteins and damage of DNA (Götz et al., 1994). It has been hypothesized, that normal aging is a result of permanent oxidative stress (Harman, 1956). Normal age-related radical damage is caused by environmental factors (chemicals, UV radiation, cosmic rays) and endogenous factors including the constant electron leakage in the mitochondrial respiratory chain (Zoccarato et al., 1988), the generation of superoxide and hydrogen peroxide by several enzyme systems, the formation of alkoxy and peroxy radicals from lipids, autooxidation and oxidative deamination of dopamine and the catalytic activity of iron (Götz et al., 1994). On the other hand detoxifying enzymes, e.g. glutathione peroxidase, gluthathione reductase, superoxide dismutase and catalase together with antioxidant mechanisms such as the glutathione system and vitamin E, C and A are involved in the defense system against radical injury (Halliwell and Gutteridge, 1984). An imbalance between the formation of oxygen free radicals due to a increased biosythesis or intake of toxins generating radicals and the protective mechanisms has been proposed as a major factor not only for normal aging, but also for pathological neurodegenerative processes and Alzheimer’s disease in particular (Götz et al., 1994; Smith et al., 1995a).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adams IM (1991) Structural plasticity of synapses in Alzheimer’s disease. Mol Neurobiol 5: 411–419
Adams JD, Klaidman LK, Odunze IN, Shen HC, Miller CA (1991) Alzheimer’s disease and Parkinson’s disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol 14: 213–226
Adolfsson R, Gottfries C-G, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034
Ahlskog JE, Uitti RJ, Low PA, Tyce GM, Nickander KK, Petersen RC, Kokmen E (1995) No evidence for systemic oxidant stress in Parkinson’s or Alzheimer’s disease. Mov Disord 10: 566–573
Alzheimer A (1907) Über eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiat 64: 146–148
Andorn AC, Britton RS, Bacon BR (1990) Evidence that lipid peroxidation and total iron are increased in Alzheimer’s brain [abstract]. Neurobiol Aging 11: 316
Anneren G, Gardner A, Lundin T (1986) Increased glutathion peroxidase activity in erythrocytes in patients with Alzheimer’s disease/senile dementia of Alzheimer’s type. Acta Neurol Scand 73: 586–589
Aruoma OI, Halliwell B, Laughton MJ, Quinlan GJ, Gutteridge JMC (1989) The mechanism of initiation of lipid peroxidation. Evidence against a requirement for an iron(II)-iron(III) complex. Biochem J 258: 617–620
Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D’Agostino RB (1993) Incidence of dementia and probable Alzheimer’s disease in a general population: the Framingham Study. Neurology 43: 515–519
Balazs L, Leon M (1994) Evidence of an oxidative challenge in the Alzheimer’s brain. Neurochem Res 19: 1131–1137
Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR (1994) In vivo evaluation of brain iron in Alzheimer’s disease and normal subjects using MRI. Biol Psychiatry 35: 480–487
Bauer J (1994) Die Alzheimer Krankheit. Neurobiologie, Psychosomatik, Diagnostik und Therapie. Schattauer, Stuttgart
Bauer J, Berger M (1993) Neuropathologie, Immunologie und psychobiologische Aspekte der Alzheimer Krankheit. Fortschr Neurol Psychiatr 61: 225–240
Banyes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405–412
Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38: 357–366
Beal MF (1996) Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 6: 661–666
Benzi G, Moretti A (1995) Are reactive oxygen species involved in Alzheimer’s disease? Neurobiol Aging 16: 661–674
Benzi G, Marzatico F, Pastoris O, Villa RF (1989) Influence of oxidative stress on the age-linked alterations of the cerebral glutathione system. J Neurosci Res 26: 120–128
Blass JP, Baker AC, Ko L, Black RS (1990) Induction of Alzheimer antigen an uncoupler of oxidative phosphorylation. Arch Neurol 47: 864–869
Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239–259
Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature 378: 776–779
Ceballos-Picot I, Merad-Boudia M, Nicole A, Thevenin M, Hellier G, Legrain S, Berr C (1996) Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer’s type — place of the extracellular glutathion peroxidase. Free Radic Biol Med 20: 579–587
Chen L, Richardson JS, Caldwell JE, Ang LC (1994) Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer’s disease and from nondemented controls. Int J Neurosci 75: 83–90
Colton CA, Gilbert DL (1987) Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 223: 284–288
Connor JR, Snyder BS, Beard JL, Fine RE, Mufson EJ (1992a) Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer’s disease. J Neurosci Res 31: 327–335
Connor JR, Menzies SL, St. Martin SM, Mufson EJ (1992b) A histochemical study of iron, transferrin, and ferritin in Alzheimer’s diseased brains. Neurosci Res 31: 75–83
Connor JR, Tucker P, Johnson M, Snyder B (1993) Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer’s disease. Neurosci Lett 159: 88–90
Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) Platelet MAO-B activity and the psychopathology of Parkinson’s disease, senile dementia and multiinfarct dementia. Acta Psychiatr Scand 78: 730–736
Delamarche C (1989) A homologous domain between the amyloid protein of Alzheimer’s disease and the neurofilament subunits. Biochimie 71: 853–856
Dyrks T, Dyrks E, Hartmann T, Masters C, Beyreuther KE (1992) Amyloidogenicity of β A4 and β A4-bearing amyloid protein precursor fragments by metal-catalyzed oxidation. J Biol Chem 267: 18210–18217
Ebrahim S, Schupf S, Silverman W, Zigman WB, Moretz RC, Wisniewski HM, Taylor E, Devakumar M, Lindegard B, Lindesay J, Grant DJ, McMurdo MET, Corrigan FM, Reynolds GP, Ward NI, Farrar G, Blair JA, Curran S, Hindmarch I, Steer C (1989) Aluminium and Alzheimer’s disease. Lancet ii: 267–269
Ehmann WD, Markesbery WR, Alauddin M, Hossain TIM, Brubaker EH (1986) Brain trace elements in Alzheimer’s disease. Neurotoxicology 7: 195–206
Fischer P, Götz ME, Ellinger B, Streifler M, Riederer P, Danielczyk W (1994) Platelet monoamine oxidase B activity and vitamin B12 in dementia. Biol Psychiat 35: 772–774
Fleming J, Joshi JG (1987) Ferritin: isolation of aluminium-ferritin complex from brain. Proc Natl Acad Sci 84: 7866–7870
Frölich L, Riederer P (1995) Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Arzneimittelforschung 43: 443–446
Gautrin D, Gauthier S (1989) Alzheimer’s disaese: environmental factors and etiologic hypothesis. Can J Neurol Sci 16: 375–387
Gerlach M, Ben Shachar D, Riederer P, Youdim MB (1994) Altered metabolism of iron as a cause of neurodegenerative diseases? J Neurochem 63: 793–807
Götz ME, Freyberger A, Hauer E, Burger R, Sofic E, Gsell W, Heckers S, Jellinger K, Hebenstreit G, Frölich L, Beckmann H, Riederer P (1992) Susceptibility of brains from patients with Alzheimer’s disease to oxygen-stimulated lipid peroxidation and differential scanning calorimetry. Dementia 3: 213–222
Götz ME, Dirr A, Freyberger A, Burger R, Riederer P (1993) The thiobarbituric acid assay reflects susceptibility to oxygen-induced lipid peroxidation in vitro rather than levels of lipid hydroperoxides in vivo: a methodological approach. Neurochem Int 22: 255–262
Götz ME, Künig G, Riederer P, Youdim MBH (1994) Oxidative stress: free radical production in neuronal degeneration. Pharmac Ther 63: 37–122
Götz ME, Fischer P, Gsell W, Riederer P, Streifler M, Simanyi M, Müller F, Danielczyk W (1998) Platelet monoamine oxidase B activity in dementia: a 4 Year follow up. Dementia 9: 74–77
Good PF, Perl DP, Bierer LM, Schmeidler J (1992) Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer’s disease: a laser microprobe (LAMMA) study. Ann Neurol 31: 286–292
Greenamyre JT, Maragos WF (1993) Neurotransmitter receptors in Alzheimer disease. Cerebrovasc Brain Metab Rev 5: 61–94
Greenlund LJ, Deckwerth TL, Johnson EM Jr (1995) Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14: 303–315
Grootveld M, Halliwell B (1986) Aromatic hydroxylation as a potential measure of hydroxyl radical formation in vivo. Biochem J 237: 499–504
Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG (1990) Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl) 81: 105–110
Gsell W, Conrad R, Hickethier M, Sofic E, Frölich L, Wichart I, Jellinger K, Moll G, Ransmayr G, Beckmann H, Riederer P (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brain of patients with dementia of Alzheimer type. J Neurochem 64: 1216–1223
Gutteridge JM, Quinlan GJ, Clark I, Halliwell B (1985) Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts. Biochim Biophys Acta 835: 441–447
Halliwell B, Gutteridge JM (1984) Oxygen toxicity, transition metals and disease. Biochem J 219: 1–14
Hajimohammadreza I, Brammer M (1990) Brain membrane fluidity and lipid peroxidation in Alzheimer’s disease. Neurosci Lett 112: 333–337
Harman D (1956) Ageing: a theory based on free radical and rediation chemistry. J Gerontol 11: 298–300
Hoyer S (1996) Oxidative metabolism deficiencies in brains of patients with Alzheimer’s disease. Acta Neuropathol Scand [Suppl] 165: 18–24
Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G (1989) Lipid peroxidation and free radical scavengers in Alzheimer’s disease. Gerontology 35: 275–282
Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB 1990) Brain iron and ferritin in Parkinson’s and Alzheimer’s diseases. J Neural Transm [PD-Sect] 2: 327–340
Kala SV, Hasinoff BB, Richardson JS (1996) Brain samples from Alzheimer’s patients have elevated levels of loosely bound iron. Int J Neurosci 86: 263–269
Kawai M, Kalaria RN, Cras P, Siedlak SL, Velasco ME, Shelton ER, Chan HW, Greenberg BD, Perry G (1993) Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer’s disease. Brain Res 623: 142–146
Kawamata T, Tooyama I, Yamada T, Walker DG, McGeer PL (1993) Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 142: 1574–1585
Kish SJ, Morito CL, Hornykiewicz O (1986) Brain glutathione peroxidase in neurodegenerative disorders. Neurochem Pathol 4: 23–28
Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain of Alzheimer’s disease. Neurology 45: 1594–1601
Maggio JE, Stimson ER, Ghilardi JR, Allen CJ, Dahl CE, Whitcomb DC, Vigna SR, Vinters HV, Labenski ME, Mantyh PW (1992) Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89: 5462–5466
Makar TK, Cooper AJ, Tofel-Grehl B, Thaler HAT, Blass JP (1995) Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem Res 20: 705–711
Margaglione M, Garofano R, Cirillo F, Ruocco A, Grandone E, Vecchione G, Milan G, di Minno G, de Blasi A, Postiglione A (1995) Cu/Zn superoxide dismutase in patients with non-familial Alzheimer’s disease. Aging Milano 7: 49–54
Markesberry W, Ehmann WD (1994) In: Terry RD, Katzman R, Bick L (eds) Alzheimer’s disease. Raven Press, New York, pp 353–367
Marklund SL, Adolffson R, Gottfries CG, Winblad B (1985) Superoxide isoenzymes in normal brains and in brains from patients with dementia of Alzheimer type. J Neurol Sci 67: 319–325
Marttila RJ, Röytta M, Lorentz H, Rinne UK (1988) Oxygen toxicity protecting enzymes in the human brain. J Neural Transm 74: 87–95
Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12: 379–389
McCord J, Fridovich I (1988) Superoxide dismutase: the first twenty Years (1968–1988). Free Radic Biol Med 5: 363–369
McMillian M, Kong LY, Sawin SM, Wilson B, Das K, Hudson P, Hong JS, Bing G (1995) Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem Biophys Res Commun 215: 572–577
Metcalfe T, Bowen DM, Müller DP (1989) Vitamin E concentrations in human brain from patients with Alzheimer’s disease, fetuses with Down’s syndrome, cetenarians, and controls. Neurochem Res 14: 1209–1212
Meccoci P, MacGarvey MS, Beal MF (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease. Ann Neurol 36: 747–751
Morris CM, Candy JM, Kerwin JM, Edwardson JA (1994) Transferrin receptors in the normal human hippocampus and in Alzheimer’s disease. Neuropathol Appl Neurobiol 20: 473–477
Mullarkey CJ, Edelstein D, Brownlee M (1990) Free radical generation by early glycation products: a mechanism of accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173: 923–929
Nitsch RM, Pittas AG, Blusztajin JK, Slack BE, Growdon HJ (1991) Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer’s disease. Ann NY Acad Sci 640: 110–113
Nitsch RM, Blusztajin JK, Pittas AG, Slack BE, Growdon JH, Wurtman RD (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci 89: 1671–1675
Oreland L, Gottfries CG (1986) Brain monoamine oxidase in aging and in dementia of Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry 10: 533–540
Palmer AM, Burns MA (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer’s disease. Brain Res 645: 338–342
Perl DP, Good PF (1992) Aluminium and the neurofibrillary tangle: results of tissue microprobe studies. Ciba Found Symp 169: 217–227
Perrin R, Briancon S, Jaendel C, Artur Y, Min A, Penin F, Siest G (1990) Blood activity of Cu/Zn superoxide dismutase, glutathione peroxidase and catalase in Alzheimer’s disease: a case-control study. Gerontology 36: 306–313
Quinlan GJ, Halliwell B, Moorhouse CP, Gutteridge JMC (1988) Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions. Biochim Biophys Acta 962:196–200
Richardson JS (1993) Free radicals in the genesis of Alzheimer’s disease. Ann NY Acad Sci 695: 73–76
Riederer P, Youdim MBH (1993) The therapeutic place and value of present and future MAO-B inhibitors — L-deprenyl as the gold standard. In: Szeleny I (ed) Inhibitors of monoamine oxidase B. Pharmacology and clinical use in neurodegenerative disorders. Birkhäuser, Basel, pp 327–338
Selkoe DJ, Ihara Y, Salazar F (1982) Alzheimer disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea. Science 215: 1243–1245
Shaw PJ (1992) Excitatory amino acid neurotransmission, excitotoxicity and excitotoxins. Curr Opin Neurol Neurosurg 5: 383–390
Smith CD, Corney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR (1991) Excess brain protein peroxidation and enzyme dysfunction in normal aging and Alzheimer’s disease. Am J Pathol 145: 42–47
Smith MA, Taneda S, Richey PL, Yan S-D, Sayre LM, Monnier VM, Perry G (1994) Advanced Mallard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91: 5710–5714
Smith MA, Sayre L, Perry G (1995a) Is Alzheimer’s a disease of oxidative stress? Alz Dis Rev 1: 63–67
Smith MA, Sayre ML, Monnier VM, Perry G (1995b) Radical AGEing in Alzheimer’s disease. Trends Neurosci 18: 172–176
Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996a) Oxidative damage in Alzheimer’s. Nature 382: 120–121
Smith MA, Sayre ML, Monnier VM, Perry G (1996b) Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenetic role in the formation of senile plaques and neurofibrillary tangles. Mol Chem Neuropathol 28: 41–48
Sofic E, Frölich L, Riederer P, Jellinger K, Heckers S, Beckmann H, Deinzer E, Pantucek F, Hebenstreit G, Ransmayr (1991) Biochemical membrane constituents and activities of alkaline and acid phosphatase and cathepsin in cortical and subcortical brain areas in dementia of the Alzheimer type. Dementia 2: 39–44
St George-Hyslop PH, Haines JL, Farrer, Polinsky R, van Broeckhoven C, Goate A, McLachlan DR, Orr H, Bruni HC (1990) Genetic linkage studies suggest that Alzheimer’s disease is not a single homogeneous disorder. FAD Collaborative Study Group. Nature 347: 194–197
Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer’s cortex show increased lipid peroxidation in vitro. J Neurochem 55: 342–345
Sulkava R, Nordberg UR, Erkinjuntti T, Westermarck T (1986) Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer’s disease and other dementias. Acta Neurol Scand 73: 487–489
Thome J, Kornhuber J, Münch G, Schinzel R, Taneli Y, Zielke B, Rösler M, Riederer P (1996) Neue Hypothese zur Athiopathogenese des Alzheimer-Syndroms — Advanced glycation end products (AGEs). Nervenarzt 67: 924–929
Thome J, Zhang J, Davids E, Foley P, Weijers H-G, Wiesbeck GA, Böning J, Riederer P, Gerlach M (1997a) Evidence for increased oxidative stress in alcohol-dependent patients provided by quantification of in vivo salicylate hydroxylation products. Alcohol Clin Exp Res 21: 82–85
Thome J, Gsell W, Rösier M, Kornhuber J, Frölich L, Hashimoto E, Zielke B, Wiesbeck GA, Riederer P (1997b) Oxidative-stress associated parameters (lactoferrin, superoxide dismutase) in serum of patients with Alzheimer’s disease. Life Sci 60: 13–19
Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE (1988) Regional brain trace-element studies in Alzheimer’s disease. Neurotoxicology 9: 1–7
Troncoso JC, Costello A, Watson AL, Johnson GVW (1993) In vitro polymerization of oxidized tau into filaments. Brain Res 613: 313–316
Urakami K, Sato K, Okada A, Mura T, Shimomura T, Takenaka T, Wakutani Y, Oshima T, Adachi Y, Takahashi K et al. (1995) Cu, Zn superoxide dismutase in patients with dementia of the Alzheimer type. Acta Neurol Scand 91: 165–168
van Rensburg SJ, Carstens ME, Potocnik FC, van der Spuy G, van der Walt BJ, Taljaard JJ (1995) Transferrin C2 and Alzheimer’s disease: another piece of the puzzle found? Med Hypotheses 44: 268–272
Vitek MP, Bhattacharya K, Glendening JM, Stopa E, Vlassara H, Bucala R, Manogue K, Cerami A (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91: 4766–4770
Vlassara H, Li YM, Imani F, Wojciechowicz D, Yang Z, Liu FT, Cerami A (1995) Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol Med 1:634–646
Wallace DC (1992) Mitochondrial genetics: a paradigm for aging and degenerative diseases? Science 256: 628–632
Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM (1996) RAGE and amyloid-b peptide neurotoxicity in Alzheimer’s disease. Nature 382: 685–691
Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC (1992) Plasma concentrations of vitamins A and E and carotenoids in Alzheimer’s disease. Age Ageing 21: 91–94
Zemlan FP, Thienhaus OJ, Bosmann HB (1989) Superoxide dismutase activity in Alzheimer’s disease: possible mechanism for paired helical filament formation. Brain Res 476: 160–162
Zhou Y, Richardson JS, Mombourquette MJ, Weil JA (1995) Free radical formation in autopsy samples of Alzheimer and control cortex. Neurosci Lett 195: 89–92
Zoccarato F, Cavallini L, Deana R, Alexandre A (1988) Pathways of hydrogen peroxide generation in guinea pig cerebral cortex mitochondria. Biochem Biophy Res Commun 154: 727–734
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Retz, W., Gsell, W., Münch, G., Rösler, M., Riederer, P. (1998). Free radicals in Alzheimer’s disease. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_22
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7508-8_22
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83112-0
Online ISBN: 978-3-7091-7508-8
eBook Packages: Springer Book Archive